{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:02:06Z","timestamp":1794024126821,"version":"4.8.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-025-01041-x","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T09:04:32Z","timestamp":1756803872000},"page":"1621-1637","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["An MRI\u2013pathology foundation model for noninvasive diagnosis and grading of prostate cancer"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8974-6540","authenticated-orcid":false,"given":"Lizhi","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6239-6333","authenticated-orcid":false,"given":"Haibin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiazi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4572-6545","authenticated-orcid":false,"given":"Pei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3141-2609","authenticated-orcid":false,"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0260-1611","authenticated-orcid":false,"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3370-3365","authenticated-orcid":false,"given":"Shudong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9205-7888","authenticated-orcid":false,"given":"Shancheng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"1041_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L. et al. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"1041_CR2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","volume":"29","author":"JI Epstein","year":"2005","unstructured":"Epstein, J. I. et al. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am. J. Surg. Pathol. 29, 1228\u20131242 (2005).","journal-title":"Am. J. Surg. Pathol."},{"key":"1041_CR3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.eururo.2022.01.018","volume":"82","author":"RA Godtman","year":"2022","unstructured":"Godtman, R. A. et al. The association between age, prostate cancer risk, and higher Gleason score in a long-term screening program: results from the G\u00f6teborg-1 prostate cancer screening trial. Eur. Urol. 82, 311\u2013317 (2022).","journal-title":"Eur. Urol."},{"key":"1041_CR4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0000000000000820","volume":"41","author":"JI Epstein","year":"2017","unstructured":"Epstein, J. I. et al. Contemporary Gleason grading of prostatic carcinoma: an update with discussion on practical issues to implement the 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am. J. Surg. Pathol. 41, e1\u2013e7 (2017).","journal-title":"Am. J. Surg. Pathol."},{"key":"1041_CR5","doi-asserted-by":"crossref","first-page":"e233337","DOI":"10.1148\/radiol.233337","volume":"312","author":"B Oerther","year":"2024","unstructured":"Oerther, B. et al. Update on PI-RADS version 2.1 diagnostic performance benchmarks for prostate MRI: systematic review and meta-analysis. Radiology 312, e233337 (2024).","journal-title":"Radiology"},{"key":"1041_CR6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet, N. et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur. Urol. 79, 243\u2013262 (2021).","journal-title":"Eur. Urol."},{"key":"1041_CR7","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.22.00123","volume":"40","author":"SE Eggener","year":"2022","unstructured":"Eggener, S. E. et al. Low-grade prostate cancer: time to stop calling it cancer. J. Clin. Oncol. 40, 3110\u20133114 (2022).","journal-title":"J. Clin. Oncol."},{"key":"1041_CR8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.eururo.2021.12.007","volume":"81","author":"PM Willemse","year":"2022","unstructured":"Willemse, P. M. et al. Systematic review of active surveillance for clinically localised prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy. Eur. Urol. 81, 337\u2013346 (2022).","journal-title":"Eur. Urol."},{"key":"1041_CR9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41585-019-0193-3","volume":"16","author":"SL Goldenberg","year":"2019","unstructured":"Goldenberg, S. L. et al. A new era: artificial intelligence and machine learning in prostate cancer. Nat. Rev. Urol. 16, 391\u2013403 (2019).","journal-title":"Nat. Rev. Urol."},{"key":"1041_CR10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.euf.2017.05.011","volume":"5","author":"DD Yang","year":"2019","unstructured":"Yang, D. D. et al. Risk of upgrading and upstaging among 10 000 patients with Gleason 3 + 4 favorable intermediate-risk prostate cancer. Eur. Urol. Focus 5, 69\u201376 (2019).","journal-title":"Eur. Urol. Focus"},{"key":"1041_CR11","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41585-022-00638-6","volume":"19","author":"H Van Poppel","year":"2022","unstructured":"Van Poppel, H. et al. Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future. Nat. Rev. Urol. 19, 562\u2013572 (2022).","journal-title":"Nat. Rev. Urol."},{"key":"1041_CR12","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-021-02230-y","volume":"20","author":"SW Merriel","year":"2022","unstructured":"Merriel, S. W. et al. Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients. BMC Med. 20, 54 (2022).","journal-title":"BMC Med."},{"key":"1041_CR13","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed, H. U. et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389, 815\u2013822 (2017).","journal-title":"Lancet"},{"key":"1041_CR14","doi-asserted-by":"crossref","first-page":"110268","DOI":"10.1016\/j.ejrad.2022.110268","volume":"150","author":"L Yang","year":"2022","unstructured":"Yang, L. et al. Association of prostate zonal volume with location and aggressiveness of clinically significant prostate cancer: a multiparametric MRI study according to PI-RADS version 2.1. Eur. J. Radiol. 150, 110268 (2022).","journal-title":"Eur. J. Radiol."},{"key":"1041_CR15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","volume":"69","author":"JC Weinreb","year":"2016","unstructured":"Weinreb, J. C. et al. PI-RADS prostate imaging-reporting and data system: 2015, version 2. Eur. Urol. 69, 16\u201340 (2016).","journal-title":"Eur. Urol."},{"key":"1041_CR16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jamaoncol.2022.5252","volume":"9","author":"S Hao","year":"2023","unstructured":"Hao, S. et al. Cost-effectiveness of prostate cancer screening using magnetic resonance imaging or standard biopsy based on the STHLM3-MRI study. JAMA Oncol. 9, 88\u201394 (2023).","journal-title":"JAMA Oncol."},{"key":"1041_CR17","doi-asserted-by":"crossref","first-page":"e223128","DOI":"10.1148\/radiol.223128","volume":"307","author":"B Turkbey","year":"2023","unstructured":"Turkbey, B. & Purysko, A. S. PI-RADS: where next? Radiology 307, e223128 (2023).","journal-title":"Radiology"},{"key":"1041_CR18","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan, V. et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N. Engl. J. Med. 378, 1767\u20131777 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1041_CR19","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1910038","volume":"382","author":"M Ahdoot","year":"2020","unstructured":"Ahdoot, M. et al. MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis. N. Engl. J. Med. 382, 917\u2013928 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1041_CR20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s41585-022-00684-0","volume":"20","author":"MJ Connor","year":"2023","unstructured":"Connor, M. J. et al. Landmarks in the evolution of prostate biopsy. Nat. Rev. Urol. 20, 241\u2013258 (2023).","journal-title":"Nat. Rev. Urol."},{"key":"1041_CR21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.euo.2023.04.004","volume":"6","author":"IC Weinstein","year":"2023","unstructured":"Weinstein, I. C. et al. Impact of magnetic resonance imaging targeting on pathologic upgrading and downgrading at prostatectomy: a systematic review and meta-analysis. Eur. Urol. Oncol. 6, 355\u2013365 (2023).","journal-title":"Eur. Urol. Oncol."},{"key":"1041_CR22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.euo.2019.08.001","volume":"3","author":"S Goel","year":"2020","unstructured":"Goel, S. et al. Concordance between biopsy and radical prostatectomy pathology in the era of targeted biopsy: a systematic review and meta-analysis. Eur. Urol. Oncol. 3, 10\u201320 (2020).","journal-title":"Eur. Urol. Oncol."},{"key":"1041_CR23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.eururo.2023.11.013","volume":"85","author":"O Bratt","year":"2024","unstructured":"Bratt, O. et al. Population-based organised prostate cancer testing: results from the first invitation of 50-year-old men. Eur. Urol. 85, 207\u2013214 (2024).","journal-title":"Eur. Urol."},{"key":"1041_CR24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/10815589241279414","volume":"73","author":"CJ Mikulas","year":"2025","unstructured":"Mikulas, C. J., Ali, K. & Onteddu, N. Prostate cancer screening: is it time for a new approach? A review article. J. Invest. Med. 73, 27\u201334 (2025).","journal-title":"J. Invest. Med."},{"key":"1041_CR25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41585-021-00447-3","volume":"18","author":"W Ranasinghe","year":"2021","unstructured":"Ranasinghe, W. et al. Optimizing the diagnosis and management of ductal prostate cancer. Nat. Rev. Urol. 18, 337\u2013358 (2021).","journal-title":"Nat. Rev. Urol."},{"key":"1041_CR26","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1001\/jamaoncol.2023.2954","volume":"9","author":"S Chen","year":"2023","unstructured":"Chen, S. et al. Use of artificial intelligence chatbots for cancer treatment information. Jama Oncol. 9, 1459\u20131462 (2023).","journal-title":"Jama Oncol."},{"key":"1041_CR27","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/s43018-022-00436-4","volume":"3","author":"A Shmatko","year":"2022","unstructured":"Shmatko, A. et al. Artificial intelligence in histopathology: enhancing cancer research and clinical oncology. Nat. Cancer 3, 1026\u20131038 (2022).","journal-title":"Nat. Cancer"},{"key":"1041_CR28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41591-021-01620-2","volume":"28","author":"W Bulten","year":"2022","unstructured":"Bulten, W. et al. Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge. Nat. Med. 28, 154\u2013163 (2022).","journal-title":"Nat. Med."},{"key":"1041_CR29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41591-021-01614-0","volume":"28","author":"P Rajpurkar","year":"2022","unstructured":"Rajpurkar, P. et al. AI in health and medicine. Nat. Med. 28, 31\u201338 (2022).","journal-title":"Nat. Med."},{"key":"1041_CR30","doi-asserted-by":"crossref","first-page":"e230138","DOI":"10.1148\/ryai.230138","volume":"6","author":"M Fassia","year":"2024","unstructured":"Fassia, M. et al. Deep learning prostate MRI segmentation accuracy and robustness: a systematic review. Radiol. Artif. Intell. 6, e230138 (2024).","journal-title":"Radiol. Artif. Intell."},{"key":"1041_CR31","doi-asserted-by":"crossref","DOI":"10.1186\/s40779-023-00464-w","volume":"10","author":"L Zhao","year":"2023","unstructured":"Zhao, L. et al. What benefit can be obtained from magnetic resonance imaging diagnosis with artificial intelligence in prostate cancer compared with clinical assessments? Military Med. Res. 10, 29 (2023).","journal-title":"Military Med. Res."},{"key":"1041_CR32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41391-023-00684-0","volume":"27","author":"A Baydoun","year":"2024","unstructured":"Baydoun, A. et al. Artificial intelligence applications in prostate cancer. Prostate Cancer Prostatic Dis. 27, 37\u201345 (2024).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"1041_CR33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41585-022-00648-4","volume":"20","author":"T Barrett","year":"2023","unstructured":"Barrett, T. et al. Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway. Nat. Rev. Urol. 20, 9\u201322 (2023).","journal-title":"Nat. Rev. Urol."},{"key":"1041_CR34","doi-asserted-by":"crossref","first-page":"e222276","DOI":"10.1148\/radiol.222276","volume":"307","author":"CA Hamm","year":"2023","unstructured":"Hamm, C. A. et al. Interactive explainable deep learning model informs prostate cancer diagnosis at MRI. Radiology 307, e222276 (2023).","journal-title":"Radiology"},{"key":"1041_CR35","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S1470-2045(24)00220-1","volume":"5","author":"A Saha","year":"2024","unstructured":"Saha, A. et al. Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study. Lancet Oncol. 5, 879 (2024).","journal-title":"Lancet Oncol."},{"key":"1041_CR36","doi-asserted-by":"crossref","first-page":"e232635","DOI":"10.1148\/radiol.232635","volume":"312","author":"JC Cai","year":"2024","unstructured":"Cai, J. C. et al. Fully automated deep learning model to detect clinically significant prostate cancer at MRI. Radiology 312, e232635 (2024).","journal-title":"Radiology"},{"key":"1041_CR37","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00330-024-11012-y","volume":"35","author":"SJ Fransen","year":"2025","unstructured":"Fransen, S. J. et al. Patient perspectives on the use of artificial intelligence in prostate cancer diagnosis on MRI. Eur. Radiol. 35, 769\u2013775 (2025).","journal-title":"Eur. Radiol."},{"key":"1041_CR38","first-page":"f837","volume":"9","author":"G Su","year":"2023","unstructured":"Su, G. et al. Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets. Sci. Adv. 9, f837 (2023).","journal-title":"Sci. Adv."},{"key":"1041_CR39","doi-asserted-by":"crossref","first-page":"102288","DOI":"10.1016\/j.media.2021.102288","volume":"75","author":"I Bhattacharya","year":"2022","unstructured":"Bhattacharya, I. et al. Selective identification and localization of indolent and aggressive prostate cancers via CorrSigNIA: an MRI\u2013pathology correlation and deep learning framework. Med. Image Anal. 75, 102288 (2022).","journal-title":"Med. Image Anal."},{"key":"1041_CR40","doi-asserted-by":"crossref","first-page":"e222830","DOI":"10.1148\/radiol.222830","volume":"308","author":"Z Shi","year":"2023","unstructured":"Shi, Z. et al. MRI-based quantification of intratumoral heterogeneity for predicting treatment response to neoadjuvant chemotherapy in breast cancer. Radiology 308, e222830 (2023).","journal-title":"Radiology"},{"key":"1041_CR41","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s43018-022-00416-8","volume":"3","author":"RS Vanguri","year":"2022","unstructured":"Vanguri, R. S. et al. Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L) 1 blockade in patients with non-small cell lung cancer. Nat. Cancer 3, 1151\u20131164 (2022).","journal-title":"Nat. Cancer"},{"key":"1041_CR42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-023-05881-4","volume":"616","author":"M Moor","year":"2023","unstructured":"Moor, M. et al. Foundation models for generalist medical artificial intelligence. Nature 616, 259\u2013265 (2023).","journal-title":"Nature"},{"key":"1041_CR43","doi-asserted-by":"crossref","unstructured":"Nguyen, V. et al. Assessing the performance of foundation models in prostate segmentation across different ultrasound modalities. In 2024 IEEE Canadian Conference on Electrical and Computer Engineering 876\u2013880 (2024).","DOI":"10.1109\/CCECE59415.2024.10667319"},{"key":"1041_CR44","doi-asserted-by":"crossref","first-page":"e240041","DOI":"10.1148\/radiol.240041","volume":"313","author":"DD Yang","year":"2024","unstructured":"Yang, D. D. et al. AI-derived tumor volume from multiparametric MRI and outcomes in localized prostate cancer. Radiology 313, e240041 (2024).","journal-title":"Radiology"},{"key":"1041_CR45","doi-asserted-by":"crossref","unstructured":"Wilson, P. F. et al. ProstNFound: integrating foundation models with ultrasound domain knowledge and clinical context for robust prostate cancer detection. In International Conference on Medical Image Computing and Computer-Assisted Intervention 499\u2013509 (2024).","DOI":"10.1007\/978-3-031-72089-5_47"},{"key":"1041_CR46","first-page":"44501","volume":"5","author":"SG Armato III","year":"2018","unstructured":"Armato, S. G. III et al. PROSTATEx challenges for computerized classification of prostate lesions from multiparametric magnetic resonance images. J. Med. Imaging 5, 44501 (2018).","journal-title":"J. Med. Imaging"},{"key":"1041_CR47","first-page":"127","volume":"69","author":"WL Bi","year":"2019","unstructured":"Bi, W. L. et al. Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J. Clin. 69, 127\u2013157 (2019).","journal-title":"CA Cancer J. Clin."},{"key":"1041_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1145\/3625287","volume":"56","author":"C Patr\u00edcio","year":"2023","unstructured":"Patr\u00edcio, C. et al. Explainable deep learning methods in medical image classification: a survey. ACM Comput. Surv. 56, 1\u201341 (2023).","journal-title":"ACM Comput. Surv."},{"key":"1041_CR49","doi-asserted-by":"crossref","first-page":"e200029","DOI":"10.1148\/ryai.2020200029","volume":"2","author":"J Mongan","year":"2020","unstructured":"Mongan, J. et al. Checklist for Artificial Intelligence in Medical Imaging (CLAIM): a guide for authors and reviewers. Radiol. Artif. Intell. 2, e200029 (2020).","journal-title":"Radiol. Artif. Intell."},{"key":"1041_CR50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.114.014508","volume":"131","author":"GS Collins","year":"2015","unstructured":"Collins, G. S. et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Circulation 131, 211\u2013219 (2015).","journal-title":"Circulation"},{"key":"1041_CR51","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41568-020-00327-9","volume":"21","author":"A Kleppe","year":"2021","unstructured":"Kleppe, A. et al. Designing deep learning studies in cancer diagnostics. Nat. Rev. Cancer 21, 199\u2013211 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"1041_CR52","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/s42256-023-00717-2","volume":"5","author":"AS Tejani","year":"2023","unstructured":"Tejani, A. S. et al. Updating the Checklist for Artificial Intelligence in Medical Imaging (CLAIM) for reporting AI research. Nat. Mach. Intell. 5, 950\u2013951 (2023).","journal-title":"Nat. Mach. Intell."},{"key":"1041_CR53","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1158\/2159-8290.CD-23-1199","volume":"14","author":"W Lotter","year":"2024","unstructured":"Lotter, W. et al. Artificial intelligence in oncology: current landscape, challenges, and future directions. Cancer Discov. 14, 711\u2013726 (2024).","journal-title":"Cancer Discov."},{"key":"1041_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1145\/3453476","volume":"55","author":"DC Nguyen","year":"2022","unstructured":"Nguyen, D. C. et al. Federated learning for smart healthcare: a survey. ACM Comput. Surv. 55, 1\u201337 (2022).","journal-title":"ACM Comput. Surv."},{"key":"1041_CR55","first-page":"21271","volume":"33","author":"J Grill","year":"2020","unstructured":"Grill, J. et al. Bootstrap your own latent-a new approach to self-supervised learning. Adv. Neural Inf. Process. Syst. 33, 21271\u201321284 (2020).","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"1041_CR56","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1109\/TPAMI.2022.3152247","volume":"45","author":"K Han","year":"2023","unstructured":"Han, K. et al. A survey on vision transformer. IEEE Trans. Pattern Anal. Mach. Intell. 45, 87\u2013110 (2023).","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"1041_CR57","doi-asserted-by":"crossref","first-page":"106236","DOI":"10.1016\/j.cmpb.2021.106236","volume":"208","author":"F P\u00e9rez-Garc\u00eda","year":"2021","unstructured":"P\u00e9rez-Garc\u00eda, F. et al. TorchIO: a Python library for efficient loading, preprocessing, augmentation and patch-based sampling of medical images in deep learning. Comput. Meth. Programs Biomed. 208, 106236 (2021).","journal-title":"Comput. Meth. Programs Biomed."}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-01041-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-01041-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-01041-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:10:39Z","timestamp":1761847839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-025-01041-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":57,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["1041"],"URL":"https:\/\/doi.org\/10.1038\/s43018-025-01041-x","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}